---
document_datetime: 2023-09-21 21:04:58
document_pages: 1
document_pathfilename: www.ema.europa.eu/en/documents/all-authorised-presentations/docetaxel-zentiva-previously-docetaxel-winthrop-epar-all-authorised-presentations_en.pdf
document_name: docetaxel-zentiva-previously-docetaxel-winthrop-epar-all-authorised-presentations_en.pdf
version: success
processing_time: 0.6884921
conversion_datetime: 2025-12-31 02:29:15.219498
docling_version:
  docling-serve: 1.9.0
  docling-jobkit: 1.8.0
  docling: 2.66.0
  docling-core: 2.57.0
  docling-ibm-models: 3.10.3
  docling-parse: 4.7.2
  python: cpython-313 (3.13.11)
  plaform: macOS-26.2-arm64-arm-64bit-Mach-O
---
| MA (EU) Number   | (Invented) name   | Strength    |
|------------------|-------------------|-------------|
| EU/1/07/384/003  | Docetaxel Zentiva | 20 mg/1 ml  |
| EU/1/07/384/004  | Docetaxel Zentiva | 80 mg/4 ml  |
| EU/1/07/384/005  | Docetaxel Zentiva | 160 mg/8 ml |

<!-- image -->